Eurazeo Shares Rise 9% in a Week After a 40% Annual Decline
The investment company's stock is regaining ground this Wednesday, driven by a significant weekly rebound after months of sharp decline. Eurazeo is trading at 41.26 euros during the session, in a strongly performing Parisian market. However, the context is still weighed down by a nearly 40% loss over the year.
Mid-Day Trading Update
Eurazeo shares have risen by 2.13% to 41.26 euros at midday, after closing at 40.40 euros the previous day. Over the past seven days, the stock has gained 9.21%, a movement that comes after a challenging quarter: the three-month performance is at -22.59%, while the decline reaches -39.41% over a year. Technically, the price has just crossed its 20-day moving average, located at 41.15 euros, which is a short-term signal to watch. However, the stock remains far from its 50-day (46.23 euros) and 200-day (53.73 euros) moving averages, illustrating the depth of the bearish trend that has been in place for several months. The RSI, at 42, remains in a low neutral zone, with no confirmed oversold or reversal signals. The most relevant resistance is at 50.40 euros, more than 22% above the current price. This rebound occurs in a favorable market context this Wednesday: the CAC 40 is up 2.12% during the session and the SBF 120 gains 2.14%. Comparable stocks such as AXA (+2.70%) and Adyen (+3.19%) are also contributing to this general upward movement on the Parisian stock exchange.
Critical Weeks Ahead
The coming weeks will be decisive for Eurazeo. The general assembly is scheduled for May 6, 2026, followed by the publication of the first quarter revenue on May 13. These two deadlines will provide an updated reading of the group's business dynamics and strategic orientations, at a time when the stock has lost a substantial part of its valuation. The half-year results, expected on July 23, will be a major milestone to assess the investment company's ability to generate value in an environment marked by geopolitical tensions and a VIX at 31.05—a threshold synonymous with high market stress. Eurazeo, whose negative beta of -0.25 historically indicates a low correlation with major indices, could still see its trajectory influenced by the evolution of the global macroeconomic climate over the coming months. At this stage, the monthly volatility of the stock, measured at 9.64, remains contained considering the magnitude of the decline recorded over a year.
